Monash IVF Group Discloses Interim Remuneration Package for Acting CEO

MT Newswires Live
2025/07/03

Monash IVF Group (ASX:MVF) disclosed the interim remuneration for acting Chief Executive Malik Jainudeen, effective June 12, reflecting the additional responsibilities of his role during the interim period, according to a Thursday filing with the Australian bourse.

Interim remuneration includes a fixed annual salary of AU$401,007 plus a AU$228,000 higher duties allowance, along with eligibility for a short-term incentive of up to 50% of total remuneration and a long-term incentive of up to 60% of base salary, both contingent on performance criteria, the filing said.

The appointment has no fixed term, includes a three-month notice, and will revert to Jainudeen's original remuneration terms after the interim period, the filing added.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10